During palatal fusion, the midline epithelial seam between the palatal shelves
degrades to achieve mesenchymal confluence. Morphological and molecular evidence
support the theory that the epithelial-mesenchymal transition is one mechanism that
regulates palatal fusion. It appears that transforming growth factor (TGF)-β
signaling plays a role in palatal EMT. TGFβ3 is the main inducer in palatal fusion
and activates both Smad-dependent and -independent signaling pathways, including the
key EMT transcription factors, Lef1, Twist, and Snail1, in the MEE prior to the
palatal EMT program. The roles and interactions among these transcription factors
will be discussed.
Nawshad A. Palatal seam disintegration: to die or not to
die? That is no longer the question. Dev Dyn237:2643–2656, 2008.
3.
Shuler CF, Halpern DE, Guo Y, Sank AC. Medial edge
epithelium fate traced by cell lineage analysis during epithelial-mesenchymal
transformation in vivo. Dev Biol154:318–330, 1992.
4.
Hay ED. An overview of epithelio-mesenchymal
transformation. Acta Anat (Basel)154:8–20, 1995.
5.
Kaartinen V, Cui XM, Heisterkamp N, Groffen J, Shuler CF.
Transforming growth factor-beta3 regulates transdifferentiation of medial edge
epithelium during palatal fusion and associated degradation of the basement membrane.
Dev Dyn209:255–260, 1997.
6.
Nawshad A, Hay ED. TGFbeta3 signaling activates
transcription of the LEF1 gene to induce epithelial mesenchymal transformation during
mouse palate development. J Cell Biol163:1291–1301, 2003.
7.
Sun D, Griffith CM, Hay ED. Carboxyfluorescein as a marker
at both light and electron microscope levels to follow cell lineage in the embryo.
Methods Mol Biol135:357–363, 2000.
8.
LaGamba D, Nawshad A, Hay ED. Microarray analysis of gene
expression during epithelial-mesenchymal transformation. Dev Dyn234:132–142, 2005.
9.
Nawshad A, LaGamba D, Olsen BR, Hay ED. Laser capture
microdissection (LCM) for analysis of gene expression in specific tissues during
embryonic epithelial-mesenchymal transformation. Dev Dyn230:529–534, 2004.
10.
Kang P, Svoboda KK. PI-3 kinase activity is required for
epithelial-mesenchymal transformation during palate fusion. Dev Dyn225:316–321, 2002.
11.
Cuervo R, Valencia C, Chandraratna RA, Covarrubias L.
Programmed cell death is required for palate shelf fusion and is regulated by
retinoic acid. Dev Biol245:145–156, 2002.
12.
Cuervo R, Covarrubias L. Death is the major fate of medial
edge epithelial cells and the cause of basal lamina degradation during palatogenesis.
Development131:15–24, 2004.
13.
Taniguchi K, Sato N, Uchiyama Y. Apoptosis and heterophagy
of medial edge epithelial cells of the secondary palatine shelves during fusion.
Arch Histol Cytol58:191–203, 1995.
14.
Mori C, Nakamura N, Okamoto Y, Osawa M, Shiota K.
Cytochemical identification of programmed cell death in the fusing fetal mouse palate
by specific labelling of DNA fragmentation. Anat Embryol (Berl)190:21–28, 1994.
15.
Carette MJ, Ferguson MW. The fate of medial edge
epithelial cells during palatal fusion in vitro: an analysis by DiI labelling and
confocal microscopy. Development114:379–388, 1992.
16.
Jin JZ, Ding J. Analysis of cell migration,
transdifferentiation and apoptosis during mouse secondary palate fusion.
Development133: 3341–3347, 2006.
17.
Martinez-Alvarez C, Blanco MJ, Perez R, Rabadan MA,
Aparicio M, Resel E, Martinez T, Nieto MA. Snail family members and cell survival in
physiological and pathological cleft palates. Dev Biol265: 207–218, 2004.
18.
Greenburg G, Hay ED. Epithelia suspended in collagen gels
can lose polarity and express characteristics of migrating mesenchymal cells.
J Cell Biol95:333–339, 1982.
19.
Hay ED. The mesenchymal cell, its role in the embryo, and
the remarkable signaling mechanisms that create it. Dev Dyn233:706–720, 2005.
20.
Lee JM, Dedhar S, Kalluri R, Thompson EW. The
epithelial-mesenchymal transition: new insights in signaling, development, and
disease. J Cell Biol172:973–981, 2006.
21.
Griffith CM, Hay ED. Epithelial-mesenchymal transformation
during palatal fusion: carboxyfluorescein traces cells at light and electron
microscopic levels. Development116:1087–1099, 1992.
22.
Mato M, Uchiyama Y, Aikawa E, Smiley GR. Ultrastructural
changes in rat palatal epithelium after beta-aminopropionitrile.
Teratology11: 153–167, 1975.
23.
Shuler CF, Guo Y, Majumder A, Luo RY. Molecular and
morphologic changes during the epithelial-mesenchymal transformation of palatal shelf
medial edge epithelium in vitro. Int J Dev Biol35: 463–472, 1991.
24.
Xu X, Han J, Ito Y, Bringas P, Jr., Urata MM, Chai Y. Cell
autonomous requirement for Tgfbr2 in the disappearance of medial edge epithelium
during palatal fusion. Dev Biol297:238–248, 2006.
25.
Vaziri Sani F, Hallberg K, Harfe BD, McMahon AP, Linde A,
Gritli-Linde A. Fate-mapping of the epithelial seam during palatal fusion rules out
epithelial-mesenchymal transformation. Dev Biol285:490–495, 2005.
26.
Sauer B. Inducible gene targeting in mice using the
Cre/lox system. Methods14:381–392, 1998.
Yue J, Mulder KM. Transforming growth factor-beta signal
transduction in epithelial cells. Pharmacol Ther91:1–34, 2001.
29.
Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A.
TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during
epithelial-mesenchymal cell transition. Mol Biol Cell16:1987–2002, 2005.
30.
Roberts AB, Sporn MB. Differential expression of the
TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult
tissues. Mol Reprod Dev32:91–98, 1992.
31.
Cui XM, Shuler CF. The TGF-beta type III receptor is
localized to the medial edge epithelium during palatal fusion. Int J Dev
Biol44:397–402, 2000.
32.
Cui XM, Warburton D, Zhao J, Crowe DL, Shuler CF.
Immunohistochemical localization of TGF-beta type II receptor and TGF-beta3 during
palatogenesis in vivo and in vitro. Int J Dev Biol42:817–820, 1998.
33.
Fitzpatrick DR, Denhez F, Kondaiah P, Akhurst RJ.
Differential expression of TGF beta isoforms in murine palatogenesis.
Development109:585–595, 1990.
34.
Dudas M, Kim J, Li WY, Nagy A, Larsson J, Karlsson S, Chai
Y, Kaartinen V. Epithelial and ectomesenchymal role of the type I TGF-beta receptor
ALK5 during facial morphogenesis and palatal fusion. Dev Biol296:298–314, 2006.
35.
Gritli-Linde A. Molecular control of secondary palate
development. Dev Biol301:309–326, 2007.
Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP,
Howles PN, Ding J, Ferguson MW, Doetschman T. Transforming growth factor-beta 3 is
required for secondary palate fusion. Nat Genet11: 409–414, 1995.
38.
Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D,
Heisterkamp N, Groffen J. Abnormal lung development and cleft palate in mice lacking
TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat
Genet11:415–421, 1995.
39.
Taya Y, O’Kane S, Ferguson MW. Pathogenesis of cleft
palate in TGF-beta3 knockout mice. Development126:3869–3879, 1999.
40.
Yang LT, Kaartinen V. Tgfb1 expressed in the Tgfb3 locus
partially rescues the cleft palate phenotype of Tgfb3 null mutants. Dev
Biol312:384–395, 2007.
41.
Yang Y, Pan X, Lei W, Wang J, Song J. Transforming growth
factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell
cycle-dependent mechanism. Oncogene25:7235–7244, 2006.
42.
Denicourt C, Dowdy SF. Another twist in the transforming
growth factor beta-induced cell-cycle arrest chronicle. Proc Natl Acad Sci U
S A100:15290–15291, 2003.
43.
Pardali K, Kowanetz M, Heldin CH, Moustakas A. Smad
pathway-specific transcriptional regulation of the cell cycle inhibitor
p21(WAF1/Cip1). J Cell Physiol204:260–272, 2005.
44.
Takahashi E, Funato N, Higashihori N, Hata Y, Gridley T,
Nakamura M. Snail regulates p21(WAF/CIP1) expression in cooperation with E2A and
Twist. Biochem Biophys Res Commun325:1136–1144, 2004.
45.
Matsuyama S, Iwadate M, Kondo M, Saitoh M, Hanyu A,
Shimizu K, Aburatani H, Mishima HK, Imamura T, Miyazono K, Miyazawa K. SB-431542 and
Gleevec inhibit transforming growth factor-beta-induced proliferation of human
osteosarcoma cells. Cancer Res63: 7791–7798, 2003.
46.
Acloque H, Thiery JP, Nieto MA. The physiology and
pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO
Rep9:322–326, 2008.
47.
Gehris AL, Greene RM. Regulation of murine embryonic
epithelial cell differentiation by transforming growth factors beta.
Differentiation49:167–173, 1992.
48.
Cui XM, Chai Y, Chen J, Yamamoto T, Ito Y, Bringas P,
Shuler CF. TGF-beta3-dependent SMAD2 phosphorylation and inhibition of MEE
proliferation during palatal fusion. Dev Dyn227:387–394, 2003.
49.
Ahmed S, Liu CC, Nawshad A. Mechanisms of palatal
epithelial seam disintegration by transforming growth factor (TGF) beta3. Dev
Biol309:193–207, 2007.
50.
Song J. EMT or apoptosis: a decision for TGF-beta.
Cell Res17:289–290, 2007.
51.
Derynck R, Zhang Y. Intracellular signalling: the mad way
to do it. Curr Biol6:1226–1229, 1996.
52.
Cui XM, Shiomi N, Chen J, Saito T, Yamamoto T, Ito Y,
Bringas P, Chai Y, Shuler CF. Overexpression of Smad2 in Tgf-beta3-null mutant mice
rescues cleft palate. Dev Biol278:193–202, 2005.
53.
Nawshad A, LaGamba D, Hay ED. Transforming growth factor
beta (TGFbeta) signalling in palatal growth, apoptosis and epithelial mesenchymal
transformation (EMT). Arch Oral Biol49:675–689, 2004.
54.
Xu X, Han J, Ito Y, Bringas P, Jr., Deng C, Chai Y.
Ectodermal Smad4 and p38 MAPK are functionally redundant in mediating TGF-beta/BMP
signaling during tooth and palate development. Dev Cell15:322–329, 2008.
55.
Nawshad A, Lagamba D, Polad A, Hay ED. Transforming growth
factor-beta signaling during epithelial-mesenchymal transformation: implications for
embryogenesis and tumor metastasis. Cells Tissues Organs179:11–23, 2005.
56.
Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in
signalling pathways: insights into insulin action. Nat Rev Mol Cell
Biol7:85–96, 2006.
57.
Blavier L, Lazaryev A, Groffen J, Heisterkamp N, DeClerck
YA, Kaartinen V. TGF-beta3-induced palatogenesis requires matrix metalloproteinases.
Mol Biol Cell12:1457–1466, 2001.
58.
Morris-Wiman J, Burch H, Basco E. Temporospatial
distribution of matrix metalloproteinase and tissue inhibitors of matrix
metalloproteinases during murine secondary palate morphogenesis. Anat Embryol
(Berl)202:129–141, 2000.
59.
Brown NL, Yarram SJ, Mansell JP, Sandy JR. Matrix
metalloproteinases have a role in palatogenesis. J Dent Res81:826–830, 2002.
60.
Woessner JF, Jr. Role of matrix proteases in processing
enamel proteins. Connect Tissue Res39:69–73; discussion 141–149,
1998.
Thiery JP. Epithelial-mesenchymal transitions in
development and pathologies. Curr Opin Cell Biol15:740–746, 2003.
63.
Liu Y, El-Naggar S, Darling DS, Higashi Y, Dean DC. Zeb1
links epithelial-mesenchymal transition and cellular senescence.
Development135:579–588, 2008.
64.
Wakamatsu N, Yamada Y, Yamada K, Ono T, Nomura N,
Taniguchi H, Kitoh H, Mutoh N, Yamanaka T, Mushiake K, Kato K, Sonta S, Nagaya M.
Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung
disease. Nat Genet27:369–370, 2001.
65.
Pungchanchaikul P, Gelbier M, Ferretti P, Bloch-Zupan A.
Gene expression during palate fusion in vivo and in vitro. J Dent
Res84: 526–531, 2005.
66.
Leptin M. twist and snail as positive and negative
regulators during Drosophila mesoderm development. Genes Dev5:1568–1576, 1991.
67.
Leptin M, Grunewald B. Cell shape changes during
gastrulation in Drosophila. Development110:73–84, 1990.
68.
Puisieux A, Valsesia-Wittmann S, Ansieau S. A twist for
survival and cancer progression. Br J Cancer94:13–17, 2006.
69.
Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA,
Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. Twist, a master regulator
of morphogenesis, plays an essential role in tumor metastasis. Cell117:927–939, 2004.
70.
Kress W, Schropp C, Lieb G, Petersen B, Busse-Ratzka M,
Kunz J, Reinhart E, Schafer WD, Sold J, Hoppe F, Pahnke J, Trusen A, Sorensen N,
Krauss J, Collmann H. Saethre-Chotzen syndrome caused by TWIST 1 gene mutations:
functional differentiation from Muenke coronal synostosis syndrome. Eur J Hum
Genet14:39–48, 2006.
71.
Stoler J, Rogers G, Mulliken JB. The frequency of palatal
anomalies in Saethre-Chotzen syndrome. The Cleft Palate-Craniofacial
Journal, 2008.
72.
Bourgeois P, Bolcato-Bellemin AL, Danse JM, Bloch-Zupan A,
Yoshiba K, Stoetzel C, Perrin-Schmitt F. The variable expressivity and incomplete
penetrance of the twist-null heterozygous mouse phenotype resemble those of human
Saethre-Chotzen syndrome. Hum Mol Genet7:945–957, 1998.
73.
Rice R, Thesleff I, Rice DP. Regulation of Twist, Snail,
and Id1 is conserved between the developing murine palate and tooth. Dev
Dyn234:28–35, 2005.
74.
Bloch-Zupan A, Hunter N, Manthey A, Gibbins J. R-twist
gene expression during rat palatogenesis. Int J Dev Biol45:397–404, 2001.
75.
Yu W, Kamara H, Svoboda KK. The role of twist during
palate development. Dev Dyn237:2716–2725, 2008.
76.
Hornik C, Brand-Saberi B, Rudloff S, Christ B, Fuchtbauer
EM. Twist is an integrator of SHH, FGF, and BMP signaling. Anat Embryol
(Berl)209:31–39, 2004.
77.
Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers
of cell movement and survival: implications in development and cancer.
Development132:3151–3161, 2005.
78.
Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ,
del Barrio MG, Portillo F, Nieto MA. The transcription factor snail controls
epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat
Cell Biol2:76–83, 2000.
79.
Murray SA, Oram KF, Gridley T. Multiple functions of Snail
family genes during palate development in mice. Development134:1789–1797, 2007.
80.
Yu WS, Svoboda, KKH Role of Gsk3b in murine palatal
development. FASEB J22:582–584, 2008.
81.
Nieto MA. The snail superfamily of zinc-finger
transcription factors. Nat Rev Mol Cell Biol3:155–166, 2002.
82.
Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata
JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ. Rac1b and
reactive oxygen species mediate MMP-3-induced EMT and genomic instability.
Nature436:123–127, 2005.
83.
Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de
Herreros AG, Dedhar S. Inhibition of integrin linked kinase (ILK) suppresses
beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin
repressor, snail, in APC−/− human colon carcinoma cells. Oncogene20:133–140, 2001.
84.
Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC.
Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of
epithelial-mesenchymal transition. Nat Cell Biol6:931–940, 2004.
85.
Schlessinger K, Hall A. GSK-3beta sets Snail’s pace.
Nat Cell Biol6: 913–915, 2004.
86.
Liu KJ, Arron JR, Stankunas K, Crabtree GR, Longaker MT.
Chemical rescue of cleft palate and midline defects in conditional GSK-3beta mice.
Nature446:79–82, 2007.
87.
Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim NH, Cha SY, Ryu
JK, Choi YJ, Kim J, Fearon ER, Weiss SJ. A Wnt-Axin2-GSK3beta cascade regulates
Snail1 activity in breast cancer cells. Nat Cell Biol8:1398–1406, 2006.
88.
Mercado-Gomez O, Hernandez-Fonseca K,
Villavicencio-Queijeiro A, Massieu L, Chimal-Monroy J, Arias C. Inhibition of Wnt and
PI3K signaling modulates GSK-3beta activity and induces morphological changes in
cortical neurons: role of tau phosphorylation. Neurochem Res33:1599–1609, 2008.
89.
Zhang YD, Chen Z, Song YQ, Liu C, Chen YP. Making a tooth:
growth factors, transcription factors, and stem cells. Cell Res15:301–316, 2005.
90.
El-Tanani MK, Barraclough R, Wilkinson MC, Rudland PS.
Regulatory region of metastasis-inducing DNA is the binding site for T cell factor-4.
Oncogene20:1793–1797, 2001.
91.
Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J,
Montesano R, Roskelley C, Grosschedl R, Dedhar S. Cell adhesion and the
integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways.
Proc Natl Acad Sci U S A95:4374–4379, 1998.
92.
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H,
Vogelstein B, Kinzler KW. Activation of beta-catenin-Tcf signaling in colon cancer by
mutations in beta-catenin or APC. Science275:1787–1790, 1997.
93.
Jin JZ, Li Q, Higashi Y, Darling DS, Ding J. Analysis of
Zfhx1a mutant mice reveals palatal shelf contact-independent medial edge epithelial
differentiation during palate fusion. Cell Tissue Res333:29–38, 2008.
94.
Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S,
Schreiber M, Berx G, Cano A, Beug H, Foisner R. DeltaEF1 is a transcriptional
repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.
Oncogene24:2375–2385, 2005.
95.
Taniguchi CM, Tran TT, Kondo T, Luo J, Ueki K, Cantley LC,
Kahn CR. Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin
action via positive regulation of PTEN. Proc Natl Acad Sci U S A103:12093–12097, 2006.
96.
Cardona-Gomez P, Perez M, Avila J, Garcia-Segura LM,
Wandosell F. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors,
GSK3, and beta-catenin in the hippocampus. Mol Cell Neurosci25:363–373, 2004.
97.
Masszi A, Fan L, Rosivall L, McCulloch CA, Rotstein OD,
Mucsi I, Kapus A. Integrity of cell-cell contacts is a critical regulator of TGF-beta
1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J
Pathol165:1955–1967, 2004.
98.
Lewandoski M. Conditional control of gene expression in
the mouse. Nat Rev Genet2:743–755, 2001.
99.
Hayashi M, Nimura K, Kashiwagi K, Harada T, Takaoka K,
Kato H, Tamai K, Kaneda Y. Comparative roles of Twist-1 and Id1 in transcriptional
regulation by BMP signaling. J Cell Sci120:1350–1357, 2007.
100.
Massari ME, Murre C. Helix-loop-helix proteins: regulators
of transcription in eucaryotic organisms. Mol Cell Biol20:429–440, 2000.
101.
Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo
F, Nieto MA, Cano A. A new role for E12/E47 in the repression of E-cadherin
expression and epithelial-mesenchymal transitions. J Biol Chem276:27424–27431, 2001.
102.
Braybrook C, Lisgo S, Doudney K, Henderson D, Marcano AC,
Strachan T, Patton MA, Villard L, Moore GE, Stanier P, Lindsay S. Craniofacial
expression of human and murine TBX22 correlates with the cleft palate and
ankyloglossia phenotype observed in CPX patients. Hum Mol Genet11:2793–2804, 2002.
103.
Britto JA, Evans RD, Hayward RD, Jones BM. From genotype
to phenotype: the differential expression of FGF, FGFR, and TGFbeta genes
characterizes human cranioskeletal development and reflects clinical presentation in
FGFR syndromes. Plast Reconstr Surg108: 2026–2039; discussion 2040–2026,
2001.
104.
Nie XG. [Differential expression of Bmp2, Bmp4 and Bmp3 in
embryonic development of mouse anterior and posterior palate.]. Chin Med J
(Engl)118:1710–1716, 2005.
105.
Gato A, Martinez ML, Tudela C, Alonso I, Moro JA, Formoso
MA, Ferguson MW, Martinez-Alvarez C. TGF-beta(3)-induced chondroitin sulphate
proteoglycan mediates palatal shelf adhesion. Dev Biol250: 393–405, 2002.
106.
Hagiwara N, Katarova Z, Siracusa LD, Brilliant MH.
Nonneuronal expression of the GABA(A) beta3 subunit gene is required for normal
palate development in mice. Dev Biol254:93–101, 2003.
107.
Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS,
Watanabe Y, Howard E, de Lima RL, Daack-Hirsch S, Sander A, McDonald-McGinn DM,
Zackai EH, Lammer EJ, Aylsworth AS, Ardinger HH, Lidral AC, Pober BR, Moreno L,
Arcos-Burgos M, Valencia C, Houdayer C, Bahuau M, Moretti-Ferreira D, Richieri-Costa
A, Dixon MJ, Murray JC. Mutations in IRF6 cause Van der Woude and popliteal pterygium
syndromes. Nat Genet32:285–289, 2002.
108.
Lan Y, Ovitt CE, Cho ES, Maltby KM, Wang Q, Jiang R.
Odd-skipped related 2 (Osr2) encodes a key intrinsic regulator of secondary palate
growth and morphogenesis. Development131:3207–3216, 2004.
109.
Lee JM, Kim JY, Cho KW, Lee MJ, Cho SW, Kwak S, Cai J,
Jung HS. Wnt11/Fgfr1b cross-talk modulates the fate of cells in palate development.
Dev Biol314:341–350, 2008.
110.
Li Q, Ding J. Gene expression analysis reveals that
formation of the mouse anterior secondary palate involves recruitment of cells from
the posterior side. Int J Dev Biol51:167–172, 2007.
111.
Rice R, Spencer-Dene B, Connor EC, Gritli-Linde A, McMahon
AP, Dickson C, Thesleff I, Rice DP. Disruption of Fgf10/Fgfr2b-coordinated
epithelial-mesenchymal interactions causes cleft palate. J Clin
Invest113:1692–1700, 2004.
112.
Rice R, Connor E, Rice DP. Expression patterns of Hedgehog
signalling pathway members during mouse palate development. Gene Expr
Patterns6:206–212, 2006.
113.
Xu X, Bringas P, Jr., Soriano P, Chai Y. PDGFR-alpha
signaling is critical for tooth cusp and palate morphogenesis. Dev
Dyn232:75–84, 2005.
114.
Yu L, Gu S, Alappat S, Song Y, Yan M, Zhang X, Zhang G,
Jiang Y, Zhang Z, Zhang Y, Chen Y. Shox2-deficient mice exhibit a rare type of
incomplete clefting of the secondary palate. Development132: 4397–4406, 2005.
115.
Zhao Y, Guo YJ, Tomac AC, Taylor NR, Grinberg A, Lee EJ,
Huang S, Westphal H. Isolated cleft palate in mice with a targeted mutation of the
LIM homeobox gene lhx8. Proc Natl Acad Sci U S A96:15002–15006, 1999.
116.
Zoupa M, Seppala M, Mitsiadis T, Cobourne MT. Tbx1 is
expressed at multiple sites of epithelial-mesenchymal interaction during early
development of the facial complex. Int J Dev Biol50:504–510, 2006.
